Lightcast Discovery Lightcast Discovery is a company that develops a platform for manipulating cells and reagents. | ![]() Histogen Histogen is a company developing a biological platform that replaces and regenerates tissues in the body. | Chemotargets Chemotargets is a biotech company focused on the discovery and development areas of small molecule pharmaceuticals and cosmeceuticals. | ![]() Spring Bank Pharmaceuticals Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform. | ||
Founding Date | Founding Date 2019 | Founding Date 2007 | Founding Date 2007 | Founding Date 2006 | Founding Date 2002 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Cambridge, GB HQ | Locations Orlando, US HQ | Locations San Diego, US HQ | Locations Barcelona, ES HQ | Locations Hopkinton, US HQ Hopkinton, US Milford, US |
Employees | Employees 1173% decrease | Employees 3804% increase | Employees 15 | Employees 30 | Employees 303% increase |
Funding | |||||
Latest funding round | Latest funding round $ 1.6m (over 6 years ago) | Latest funding round $ 1.5m (over 13 years ago) | Latest funding round $ 6m (over 9 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 1.6m | Total funding raised $ 1.5m | Total funding raised $ 46.3m | Total funding raised N/A | Total funding raised $ 14.4m |

VaxCare is a company that builds technology to manage vaccination workflow.
View company
Histogen is a company developing a biological platform that replaces and regenerates tissues in the body.
View companyChemotargets is a biotech company focused on the discovery and development areas of small molecule pharmaceuticals and cosmeceuticals.
View company
Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
View company